» Articles » PMID: 23300966

The Role of Tobacco, Alcohol, and Obesity in Neoplastic Progression to Esophageal Adenocarcinoma: a Prospective Study of Barrett's Esophagus

Overview
Journal PLoS One
Date 2013 Jan 10
PMID 23300966
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Esophageal adenocarcinoma (EA) incidence in many developed countries has increased dramatically over four decades, while survival remains poor. Persons with Barrett's esophagus (BE), who experience substantially elevated EA risk, are typically followed in surveillance involving periodic endoscopy with biopsies, although few progress to EA. No medical, surgical or lifestyle interventions have been proven to safely lower EA risk.

Design: We investigated whether smoking, obesity or alcohol could predict progression to EA in a prospective cohort of 411 BE patients. Data were collected during personal interview. Adjusted hazard ratios (HR) were estimated using Cox regression.

Results: 39% had body mass index (BMI) over 30 and 64% had smoked cigarettes. Main analyses focused on those with at least 5 months of follow-up (33,635 person-months), in whom 45 developed EA. Risk increased by 3% per year of age (trend p-value 0.02), with approximate doubling of risk among males. EA risk increased with smoking pack-years (trend p-value 0.04) and duration (p-value 0.05). Compared to never-smokers, the HR for those in the highest pack-year tertile was 2.29 (95%CI 1.04-5.07). No association was found with alcohol or BMI, whereas a suggestion of increased risk was observed in those with higher waist-hip ratio, especially among males.

Conclusion: EA risk significantly increased with increasing age and cigarette exposure. Abdominal obesity, but not BMI, was associated with a modest increased risk. Continued follow-up of this and other cohorts is needed to precisely define these relationships so as to inform risk stratification and preventive interventions.

Citing Articles

Long-term survival and risk factors in esophageal squamous cell carcinoma: A Kaplan-Meier and cox regression study.

Ren Z, Kang M, Zhu L, Li P World J Gastrointest Surg. 2024; 16(12):3772-3779.

PMID: 39734461 PMC: 11650227. DOI: 10.4240/wjgs.v16.i12.3772.


Exploring Dietary Factors and Esophageal Adenocarcinoma: Insights From Mendelian Randomization Study.

Liu X, Yang W, Yang Y Food Sci Nutr. 2024; 12(11):9600-9606.

PMID: 39620031 PMC: 11606852. DOI: 10.1002/fsn3.4527.


Effect of smoking-related features and 731 immune cell phenotypes on esophageal cancer: a two-sample and mediated Mendelian randomized study.

Yang K, Li S, Ding Y, Meng X, Zhang C, Sun X Front Immunol. 2024; 15:1336817.

PMID: 38601154 PMC: 11004242. DOI: 10.3389/fimmu.2024.1336817.


Mortality burden and future projections of major risk factors for esophageal cancer in China from 1990 to 2019.

Wu G, Wu Q, Xu J, Gao G, Chen T, Chen G Gen Thorac Cardiovasc Surg. 2023; 72(3):192-201.

PMID: 37973657 DOI: 10.1007/s11748-023-01987-8.


Mutational signature dynamics shaping the evolution of oesophageal adenocarcinoma.

Abbas S, Pich O, Devonshire G, Zamani S, Katz-Summercorn A, Killcoyne S Nat Commun. 2023; 14(1):4239.

PMID: 37454136 PMC: 10349863. DOI: 10.1038/s41467-023-39957-6.


References
1.
Polednak A . Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer. 2003; 105(1):98-100. DOI: 10.1002/ijc.11029. View

2.
MacInnis R, English D, Hopper J, Giles G . Body size and composition and the risk of gastric and oesophageal adenocarcinoma. Int J Cancer. 2005; 118(10):2628-31. DOI: 10.1002/ijc.21638. View

3.
Loffeld R . Helicobacter pylori, obesity and gastro-oesophageal reflux disease. Is there a relation? A personal view. Neth J Med. 2005; 63(9):344-7. View

4.
. Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol. 2008; 5(9):517-26. DOI: 10.1038/ncpgasthep1223. View

5.
Sikkema M, Looman C, Steyerberg E, Kerkhof M, Kastelein F, van Dekken H . Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Am J Gastroenterol. 2011; 106(7):1231-8. DOI: 10.1038/ajg.2011.153. View